Learn / ADPT
NASDAQ: ADPT
Adaptive Biotechnologies (ADPT) stock, explained like you're 5
Adaptive Biotechnologies trades on the Nasdaq under the ticker ADPT. It is a mid cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 4.2 billion dollars.
- Ticker
- ADPT
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Biological Products (No Diagnostic Substances)
- Size
- Mid cap, about 4.2 billion dollars
Is Adaptive Biotechnologies a small, medium or large cap company?
No. Adaptive Biotechnologies is a mid cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 4.2 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Adaptive Biotechnologies makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves ADPT stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- The results webcast is scheduled for 1:30 p.m. Pacific on Nov. 4. (Stock Titan)
- Adaptive Biotechnologies Stock Has Doubled in the Past Year. Here’s What Could Come Next. (Barchart.com)
- Adaptive Biotechnologies (NASDAQ:ADPT) Stock: Insider Julie Rubinstein Sells 11,881 Shares (MarketBeat)
- Adaptive biotechnologies president & COO Rubinstein sells $897k stock (Investing.com)
- Adaptive Biotechnologies (ADPT) Stock May Be 22% Undervalued As Growth Hopes Build (Yahoo Finance)
Follow ADPT in your daily brief
Each trading day at 5 PM ET we post what happened to Adaptive Biotechnologies and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow ADPT
Questions about Adaptive Biotechnologies stock
What does Adaptive Biotechnologies do?
Adaptive Biotechnologies trades on the Nasdaq under the ticker ADPT. It is a mid cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 4.2 billion dollars.
What is the ticker symbol for Adaptive Biotechnologies?
Adaptive Biotechnologies trades under the ticker ADPT on the Nasdaq.
What is Adaptive Biotechnologies's market cap?
Adaptive Biotechnologies is a mid cap stock with a market cap of about 4.2 billion dollars.
How does Adaptive Biotechnologies make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves ADPT stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow ADPT stock every day?
Add ADPT to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.